Yijun Cai, PharmD Candidate

Treatment options are distinct in their mechanisms, safety profiles, and implications for patients’ quality of life.

In crafting a patient-centered regimen, the convergence of expertise from physicians and pharmacists, paired with the values and preferences of patients, becomes paramount.

The role of monoclonal antibodies in minimizing COVID-19–related complications remains important to assess.